1α,25-dihydroxyvitamin D 3 attenuates platelet activation and the expression of VCAM-1 and MT1-MMP in human endothelial cells

Cardiology

Volumn 118, Issue 2, 2011, Pages 107-115

  Stach, Ksenija ^a   Kälsch, Anna Isabelle ^a   Nguyen, Xuan Duc ^a   Elmas, Elif ^a   Kralev, Stefan ^a   Lang, Siegfried ^a   Weiss, Christel ^a   Borggrefe, Martin ^a   Kälsch, Thorsten ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

1 ,25 Dihydroxyvitamin D 3; Atherosclerosis; Endothelial cells; Inflammation; Platelets

Indexed keywords

CALCITRIOL; CD40 LIGAND; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE 14; NITRIC OXIDE SYNTHASE; PADGEM PROTEIN; REACTIVE OXYGEN METABOLITE; UROKINASE RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; DRUG EFFECT; ENDOTHELIAL CELL MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PLATELETS; CALCITRIOL; CD40 LIGAND; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; MATRIX METALLOPROTEINASE 14; P-SELECTIN; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 79955561670     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000327547     Document Type: Article

References (55)

1. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A: Widespread coronary inflammation in unstable angina. N Engl J Med 2002;347:5-12. (Pubitemid 34728951)
2. Libby P: Inflammation in atherosclerosis. Nature 2002;420:868-874.
3. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in woman. N Engl J Med 2000;342:836-843. (Pubitemid 30165206)
4. Zwaka TP, Hombach V, Torzewski J: C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001;103:1194-1197. (Pubitemid 32221339)
5. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM: Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000;102:1000-1006. (Pubitemid 30657516)
6. Lusis AJ: Atherosclerosis. Nature 2000;407:233-241.
7. Ruggeri ZM: Platelets in atherothrombosis. Nat Med 2002;8:1227-1234.
8. Kälsch T, Elmas E, Nguyen XD, Grebert N, Wolpert C, Kluter H, Borggrefe M, Haase KK, Dempfle CE: Enhanced coagulation activation by in vitro lipopolysaccharide challenge in patients with ventricular fibrillation complicating acute myocardial infarction. J Cardiovasc Electrophysiol 2005;16:858-863. (Pubitemid 41623776)
9. Kälsch T, Nguyen XD, Elmas E, Grebert N, Suselbeck T, Kluter H, Borggrefe M, Dempfle CE: Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide-challenge in patients with unstable angina. Int J Cardiol 2006;111:217-223. (Pubitemid 44107560)
10. Steiner S, Speidl WS, Pleiner J, Seidinger D, Zorn G, Kaun C, Wojta J, Huber K, Minar E, Wolzt M, Kopp CW: Simvastatin blunts endotoxin-induced tissue factor in vivo. Circulation 2005;111:1841-1846. (Pubitemid 40525151)
11. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591-594. (Pubitemid 28157601)
12. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P: Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998;394:200-203. (Pubitemid 28325976)
13. Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, Libby P: Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 1997;94:1931-1936. (Pubitemid 27113939)
14. Galkina E, Ley K: Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 2007;27:2292-2301. (Pubitemid 350203942)
15. Kitagawa K, Matsumoto M, Sasaki T, Hashimoto H, Kuwabara K, Ohtsuki T, Hori M: Involvement of ICAM-1 in the progression of atherosclerosis in APOE-knockout mice. Atherosclerosis 2002;160:305-310. (Pubitemid 34159322)
16. Lutgens E, Gorelik L, Daemen MJ, de Muinck ED, Grewal IS, Koteliansky VE, Flavell RA: Requirement for CD154 in the progression of atherosclerosis. Nat Med 1999;5:1313-1316. (Pubitemid 29535611)
17. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY: Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 2001;276:7614-7620.
18. Cybulsky MI, Gimbrone MA: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991;251:788-791.
19. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-2503. (Pubitemid 24379627)
20. Wallis DE, Penckofer S, Sizemore GW: The 'sunshine deficit' and cardiovascular disease. Circulation 2008;118:1476-1485.
21. Zittermann A, Schleithoff SS, Koerfer R: Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005;94:483-492. (Pubitemid 41555486)
22. Scragg R: Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. Int J Epidemiol 1981;10:337-341.
23. Fabsitz R, Feinleib M: Geographic patterns in county mortality rates from cardiovascular diseases. Am J Epidemiol 1980;111:315-328. (Pubitemid 10184068)
24. Smith WC, Tunstall-Pedoe H: European regional variation in cardiovascular mortality. Br Med Bull 1984;40:374-379. (Pubitemid 14009064)
25. Grimes DS, Hindle E, Dyer T: Sunlight, cholesterol and coronary heart disease. QJM 1996;89:579-589. (Pubitemid 26278869)
26. Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R: Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 1990;19:559-563. (Pubitemid 20331800)
27. Zipes DP: Warning: the short days of winter may be hazardous to your health. Circulation 1999;100:1590-1592.
28. Penckofer S, Kouba J, Wallis DE, Emanuele MA: Vitamin D and diabetes: let the sunshine in. Diabetes Educ 2008;34:939-940, 942, 944 passim.
29. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS: Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-511.
30. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K: Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the united states: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007;167:1159-1165. (Pubitemid 46919818)
31. Zittermann A, Frisch S, Berthold HK, Gotting C, Kuhn J, Kleesiek K, Stehle P, Koertke H, Koerfer R: Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009;89:1321-1327.
32. Kochupillai N: The physiology of vitamin D: current concepts. Indian J Med Res 2008;127:256-262.
33. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, Lappe DL, Muhlestein JB: Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010;106:963-968.
34. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-2756.
35. Wu-Wong JR, Nakane M, Ma J, Ruan X, Kroeger PE: Effects of vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis 2006;186:20-28.
36. Gawaz M, Neumann FJ, Dickfeld T, Koch W, Laugwitz KL, Adelsberger H, Langenbrink K, Page S, Neumeier D, Schomig A, Brand K: Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 1998;98:1164-1171. (Pubitemid 28436165)
37. Arroyo CM, Kan RK, Burman DL, Kahler DW, Nelson MR, Corun CM, Guzman JJ, Broomfield CA: Regulation of 1-alpha, 25-dihydroxyvitamin D3 on interleukin-6 and interleukin-8 induced by sulfur mustard (HD) on human skin cells. Pharmacol Toxicol 2003;92:204-213. (Pubitemid 36513216)
38. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB: Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 1997;94:9831-9835.
39. Bachschmid MM, van der Loo B: A new 'sunshine' in the vasculature? Circulation 2005;111:1571-1573.
40. Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O, Jaccard N, Knoll E, Stern N: 25-Hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005;111:1666-1671. (Pubitemid 40525167)
41. Wakasugi M, Noguchi T, Inoue M, Kazama Y, Tawata M, Kanemaru Y, Onaya T: Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells. Prostaglandins 1991;42:127-136.
42. O'Connell TD, Berry JE, Jarvis AK, Somerman MJ, Simpson RU: 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol 1997;272:H1751-H1758.
43. Almerighi C, Sinistro A, Cavazza A, Ciaprini C, Rocchi G, Bergamini A: 1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine 2009;45:190-197.
44. Bartels LE, Jorgensen SP, Agnholt J, Kelsen J, Hvas CL, Dahlerup JF: 1,25-Dihydroxyvitamin D3 and dexamethasone increase interleukin- 10 production in CD4+ T cells from patients with Crohn's disease. Int Immunopharmacol 2007;7:1755-1764.
45. Martinesi M, Bruni S, Stio M, Treves C: 1,25-Dihydroxyvitamin D3 inhibits tumor necrosis factor-alpha-induced adhesion molecule expression in endothelial cells. Cell Biol Int 2006;30:365-375.
46. Zhu Y, Mahon BD, Froicu M, Cantorna MT: Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 2005;35:217-224. (Pubitemid 40123868)
47. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R: Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006;83:754-759. (Pubitemid 44713136)
48. Oh J, Weng S, Felton SK, Bhandare S, Riek A, Butler B, Proctor BM, Petty M, Chen Z, Schechtman KB, Bernal-Mizrachi L, Bernal- Mizrachi C: 1,25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type II diabetes mellitus. Circulation 2009;120:687-698.
49. Rajavashisth TB, Xu XP, Jovinge S, Meisel S, Xu XO, Chai NN, Fishbein MC, Kaul S, Cercek B, Sharifi B, Shah PK: Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation 1999;99:3103-3109. (Pubitemid 29289074)
50. Li H, Cybulsky MI, Gimbrone MA, Libby P: An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 1993;13:197-204. (Pubitemid 23056792)
51. Irani K: Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000;87:179-183.
52. Wong MS, Delansorne R, Svenningsen P, Vanhoutte PM: Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 2010;299:H1226-H1234.
53. Kaneko A, Suzuki S, Hara M, Mori J, Kumagai M, Yajima H, Yamashita K, Kakizawa T, Yamazaki M, Takeda T, Miyamoto T, Ichikawa K, Hashizume K: 1,25-Dihydroxyvitamin D3 suppresses the expression of the VCAM-1 receptor, VLA-4 in human leukemic HL-60 cells. Biochem Biophys Res Commun 1999;255:371-376.
54. Loscalzo J: Nitric oxide and vascular disease. N Engl J Med 1995;333:251-253.
55. Rockett KA, Brookes R, Udalova I, Vidal V, Hill AV, Kwiatkowski D: 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 1998;66:5314-5321.